ALLIANCE PHARMA PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.33 GBX | +2.89% |
|
-0.41% | -0.41% |
| 06-19 | Transcript : Alliance Pharma plc, 2023 Earnings Call, Jun 19, 2024 | |
| 06-19 | Alliance Pharma plc Provides Preliminary Results for the Year Ended 31 December 2023 | CI |
Evolution of the average Target Price on Alliance Pharma plc
Price target over the last 5 years
History of analyst recommendation changes
a2.AQHL6PI7daIfUZ5T4iP8YELXv6ABKKqP015A93haHKI.cET_jrBLD8EnNsojq02uCCeu6vVsX9_LjBJzjjkeUPtEQorZnw0Fm0453w~2d9f0ab44ef77dda6c6216cb3048f8c3
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.392
GBP
Average target price
0.6243
GBP
Spread / Average Target
+59.26%
High Price Target
0.85
GBP
Spread / Highest target
+116.84%
Low Price Target
0.42
GBP
Spread / Lowest Target
+7.14%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Alliance Pharma plc
| Peel Hunt | |
| Berenberg Bank | |
| RBC Capital Markets |
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- APH Stock
- Consensus Alliance Pharma plc
